Yang J, Gustavsson AL, Haraldsson M, Karlsson G, Norberg T, Baltzer L
Org. Biomol. Chem. 15 (21) 4644-4654 [2017-05-31; online 2017-05-18]
A high-affinity polypeptide conjugate 4-C25L22-DQ, has been developed for the molecular recognition of the human C-reactive protein, CRP, a well-known inflammation biomarker. CRP is one of the most frequently quantified targets in diagnostic applications and a target in drug development. With the exception of antibodies, most molecular constructs take advantage of the known affinity for CRP of phosphocholine that depends on Ca
PubMed 28513744
DOI 10.1039/c7ob00684e
Crossref 10.1039/c7ob00684e